CELLECTIS S A's ticker is CLLS and the CUSIP is 15117K103. A total of 41 filers reported holding CELLECTIS S A in Q1 2017. The put-call ratio across all filers is 4.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $227,000 | -40.9% | 13,609 | 0.0% | 0.02% | -32.1% |
| Q3 2018 | $384,000 | -0.3% | 13,609 | 0.0% | 0.03% | -12.5% |
| Q2 2018 | $385,000 | -10.3% | 13,609 | 0.0% | 0.03% | +3.2% |
| Q1 2018 | $429,000 | +8.1% | 13,609 | 0.0% | 0.03% | -11.4% |
| Q4 2017 | $397,000 | +2.6% | 13,609 | 0.0% | 0.04% | -10.3% |
| Q3 2017 | $387,000 | +10.3% | 13,609 | 0.0% | 0.04% | -2.5% |
| Q2 2017 | $351,000 | +7.3% | 13,609 | 0.0% | 0.04% | +25.0% |
| Q1 2017 | $327,000 | +92.4% | 13,609 | +36.0% | 0.03% | +39.1% |
| Q4 2016 | $170,000 | -29.5% | 10,010 | 0.0% | 0.02% | -28.1% |
| Q3 2016 | $241,000 | -87.1% | 10,010 | -85.8% | 0.03% | -87.0% |
| Q2 2016 | $1,870,000 | -4.9% | 70,333 | -1.6% | 0.25% | +3.8% |
| Q1 2016 | $1,966,000 | +15.2% | 71,500 | +30.0% | 0.24% | +11.7% |
| Q4 2015 | $1,707,000 | -4.4% | 55,000 | -18.8% | 0.21% | -12.3% |
| Q3 2015 | $1,785,000 | -32.9% | 67,700 | -8.1% | 0.24% | -46.2% |
| Q2 2015 | $2,659,000 | +590.6% | 73,700 | +561.1% | 0.45% | +338.8% |
| Q1 2015 | $385,000 | – | 11,148 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $7,089,923 | 0.25% |
| OPPENHEIMER & CO INC | 121,420 | $191,844 | 0.00% |
| CREDIT SUISSE AG/ | 1,438,255 | $2,272,443 | 0.00% |
| Baillie Gifford | 1,164,009 | $1,839,135 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 656,600 | $1,037,428 | 0.00% |
| Capital International Investors | 1,848,804 | $2,921,110 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,095,966 | $1,731,626 | 0.00% |
| EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% |
| Qube Research & Technologies Ltd | 40 | $63 | 0.00% |
| Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% |